Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C019499 |
2-nitrofluorene |
2-nitrofluorene results in increased expression of CTSD mRNA | increases expression | 15890375
|
C016392 |
3,3'-diindolylmethane |
3,3'-diindolylmethane results in increased expression of CTSD mRNA | increases expression | 16192472
|
C016583 |
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CTSD mRNA | increases expression | 15890375
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of CTSD mRNA | affects expression | 17562736
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 results in increased expression of CTSD mRNA | increases expression | 15890375
|
C011512 |
alpha-naphthoflavone |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of CTSD mRNA]] | decreases reaction|increases expression | 11165043
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CTSD mRNA | affects expression | 16483693
|
D000643 |
Ammonium Chloride |
Ammonium Chloride results in increased expression of CTSD protein | increases expression | 16483693
|
D003913 |
Dextroamphetamine |
Dextroamphetamine results in decreased expression of CTSD mRNA | decreases expression | 12558987
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of CTSD mRNA | decreases expression | 17879257
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of CTSD mRNA | increases expression | 20382639
|
C006780 |
bisphenol A |
[bisphenol A results in increased activity of ESR1 protein] which results in increased expression of CTSD mRNA | increases activity|increases expression | 14754635
|
D003042 |
Cocaine |
Cocaine affects the expression of CTSD mRNA | affects expression | 15681117
|
D003300 |
Copper |
Copper affects the expression of CTSD protein | affects expression | 17192175
|
D003520 |
Cyclophosphamide |
[Cyclophosphamide co-treated with Mecamylamine] results in increased expression of CTSD mRNA | affects cotreatment|increases expression | 18433785
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of CTSD mRNA | increases expression | 20106945
|
D003687 |
Dehydroepiandrosterone |
Dehydroepiandrosterone results in increased expression of CTSD mRNA | increases expression | 18709148 17823450
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of CTSD mRNA | decreases expression | 18042831
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in increased expression of CTSD mRNA | increases expression | 15890375
|
D004128 |
Dimethylnitrosamine |
Dimethylnitrosamine results in increased expression of CTSD mRNA | increases expression | 15890375
|
D004317 |
Doxorubicin |
CTSD protein results in decreased susceptibility to Doxorubicin | decreases response to substance | 18566016
|
D004317 |
Doxorubicin |
Doxorubicin results in increased expression of CTSD protein | increases expression | 18566016
|
D004642 |
Emodin |
Emodin results in decreased expression of CTSD mRNA | decreases expression | 16045814
|
C044101 |
endotoxin, Escherichia coli |
endotoxin, Escherichia coli results in increased expression of CTSD mRNA | increases expression | 15919760
|
D004958 |
Estradiol |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of CTSD mRNA]] | decreases reaction|increases expression | 11165043
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CTSD mRNA | affects cotreatment|decreases expression | 19619570
|
D004958 |
Estradiol |
Estradiol promotes the reaction [ESR1 protein binds to CTSD promoter] | affects binding|increases reaction | 19698761
|
D004958 |
Estradiol |
Estradiol promotes the reaction [[ESR1 protein binds to CTSD promoter] which results in increased expression of CTSD mRNA] | affects binding|increases expression|increases reaction | 11165043
|
D004958 |
Estradiol |
Estradiol results in increased expression of CTSD mRNA | increases expression | 19619570 11165043 15090535 15072547 16257430 20372779 15219790 11179685 14994273
|
D004958 |
Estradiol |
[Tetrachlorodibenzodioxin binds to and results in increased activity of [AHR protein binds to ARNT protein]] inhibits the reaction [Estradiol results in increased expression of CTSD mRNA] | affects binding|decreases reaction|increases activity|increases expression | 11165043
|
D004958 |
Estradiol |
Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of CTSD mRNA] | decreases reaction|increases expression | 11165043 11179685
|
D004958 |
Estradiol |
Estradiol results in increased expression of CTSD mRNA | increases expression | 17823450 18709148 16192472
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of CTSD mRNA | increases expression | 18035473
|
C070081 |
fulvestrant |
fulvestrant results in increased expression of CTSD mRNA | increases expression | 15072547
|
C056933 |
fumonisin B1 |
fumonisin B1 results in increased expression of CTSD mRNA | increases expression | 16221962
|
D019833 |
Genistein |
Genistein results in increased expression of CTSD mRNA | increases expression | 15090535
|
D005944 |
Glucosamine |
Glucosamine affects the localization of CTSD protein | affects localization | 15972124
|
C475919 |
hydroxytamoxifen |
hydroxytamoxifen results in increased expression of CTSD mRNA | increases expression | 15072547
|
C016517 |
indole-3-carbinol |
indole-3-carbinol results in decreased expression of CTSD protein | decreases expression | 11110848
|
C016517 |
indole-3-carbinol |
indole-3-carbinol results in increased expression of CTSD mRNA | increases expression | 16192472
|
D007545 |
Isoproterenol |
Isoproterenol results in decreased activity of CTSD protein | decreases activity | 19172585
|
D007545 |
Isoproterenol |
mangiferin inhibits the reaction [Isoproterenol results in decreased activity of CTSD protein] | decreases activity|decreases reaction | 19172585
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of CTSD mRNA | increases expression | 15919760
|
C013592 |
mangiferin |
mangiferin inhibits the reaction [Isoproterenol results in decreased activity of CTSD protein] | decreases activity|decreases reaction | 19172585
|
D008464 |
Mecamylamine |
[Cyclophosphamide co-treated with Mecamylamine] results in increased expression of CTSD mRNA | affects cotreatment|increases expression | 18433785
|
D008701 |
Methapyrilene |
Methapyrilene results in increased expression of CTSD mRNA | increases expression | 15890375
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in increased expression of CTSD mRNA | increases expression | 16257430
|
D008767 |
Methylmercury Compounds |
Methylmercury Compounds results in increased expression of CTSD mRNA | increases expression | 16966085
|
D015741 |
Metribolone |
Metribolone results in decreased expression of CTSD protein | decreases expression | 17152098
|
D005996 |
Nitroglycerin |
Nitroglycerin results in decreased expression of CTSD mRNA | decreases expression | 12102619
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in increased expression of CTSD mRNA | increases expression | 17616710
|
C025256 |
nonylphenol |
[nonylphenol results in increased activity of ESR1 protein] which results in increased expression of CTSD mRNA | increases activity|increases expression | 14754635
|
D004963 |
Estrenes |
Estrenes analog results in increased expression of CTSD mRNA | increases expression | 15219790
|
C041786 |
palm oil |
palm oil results in decreased expression of CTSD mRNA | decreases expression | 18042831
|
D010269 |
Paraquat |
Paraquat results in decreased expression of CTSD mRNA | decreases expression | 16797015
|
C031375 |
pepstatin |
pepstatin results in decreased activity of CTSD protein | decreases activity | 17116725
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in increased expression of CTSD mRNA | increases expression | 18709148
|
D010615 |
Phenacetin |
Phenacetin results in increased expression of CTSD mRNA | increases expression | 17698508
|
C030299 |
phenylhydrazine |
phenylhydrazine results in increased expression of CTSD mRNA | increases expression | 17698508
|
D010882 |
Piperonyl Butoxide |
Piperonyl Butoxide results in increased expression of CTSD mRNA | increases expression | 15890375
|
C014153 |
pirimiphos methyl |
pirimiphos methyl results in decreased activity of CTSD protein | decreases activity | 9204212
|
C014153 |
pirimiphos methyl |
pirimiphos methyl results in increased activity of CTSD protein | increases activity | 9204212
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of CTSD mRNA | increases expression | 18301758
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of CTSD mRNA | increases expression | 15890375
|
D011794 |
Quercetin |
Quercetin results in increased expression of CTSD mRNA | increases expression | 15090535
|
C059514 |
resveratrol |
CTSD protein affects the reaction [resveratrol affects the localization of CYCS protein] | affects localization|affects reaction | 17116725
|
C059514 |
resveratrol |
CTSD protein affects the reaction [resveratrol promotes the reaction [BAX protein binds to BAX protein]] | affects binding|affects reaction|increases reaction | 17116725
|
C059514 |
resveratrol |
CTSD protein affects the reaction [resveratrol results in increased activity of CASP3 protein] | affects reaction|increases activity | 17116725
|
C059514 |
resveratrol |
CTSD protein affects the susceptibility to resveratrol | affects response to substance | 17116725
|
C059514 |
resveratrol |
ESR1 protein affects the reaction [resveratrol affects the secretion of CTSD protein] | affects reaction|affects secretion | 16393696
|
C059514 |
resveratrol |
resveratrol affects the expression of CTSD mRNA | affects expression | 16393696
|
C059514 |
resveratrol |
resveratrol results in increased expression of and results in increased metabolism of and affects the localization of CTSD protein | affects localization|increases expression|increases metabolic processing | 17116725
|
C059514 |
resveratrol |
[resveratrol results in increased expression of IGF2 protein] which results in increased secretion of CTSD protein | increases expression|increases secretion | 16393696
|
C059514 |
resveratrol |
resveratrol results in increased secretion of CTSD protein | increases secretion | 16393696
|
C059514 |
resveratrol |
resveratrol results in increased expression of CTSD mRNA | increases expression | 16081268
|
C009166 |
retinol acetate |
retinol acetate results in increased expression of CTSD mRNA | increases expression | 16772331
|
C410733 |
scriptaid |
scriptaid affects the expression of CTSD mRNA | affects expression | 18813790
|
C009277 |
sodium arsenate |
sodium arsenate results in increased expression of CTSD mRNA | increases expression | 16882884
|
D013749 |
Tetrachlorodibenzodioxin |
AHR protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CTSD mRNA]] | decreases reaction|increases expression|increases reaction | 11165043
|
D013749 |
Tetrachlorodibenzodioxin |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of CTSD mRNA]] | decreases reaction|increases expression | 11165043
|
D013749 |
Tetrachlorodibenzodioxin |
ARNT protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CTSD mRNA]] | decreases reaction|increases expression|increases reaction | 11165043
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CTSD mRNA | affects cotreatment|decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin binds to and results in increased activity of [AHR protein binds to ARNT protein]] inhibits the reaction [Estradiol results in increased expression of CTSD mRNA] | affects binding|decreases reaction|increases activity|increases expression | 11165043
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of CTSD mRNA] | decreases reaction|increases expression | 11179685 11165043
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin promotes the reaction [[AHR protein binds to ARNT protein] which binds to CTSD promoter] | affects binding|increases reaction | 11165043
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin promotes the reaction [[AHR protein binds to ARNT protein] which results in decreased expression of CTSD mRNA] | affects binding|decreases expression|increases reaction | 11165043
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of CTSD mRNA | decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of CTSD mRNA | increases expression | 11879969
|
D014108 |
Tosylphenylalanyl Chloromethyl Ketone |
Tosylphenylalanyl Chloromethyl Ketone results in increased expression of CTSD protein | increases expression | 10772776
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of CTSD mRNA | increases expression | 17218384 16054129
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.25 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
2.95 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.31 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
7.18 | 18653653 11850527 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
7.18 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
11.41 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Dimethylnitrosamine |
11.41 | 16033868 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
11.41 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
11.41 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
11.41 | 11473722 |
MESH:D000236 |
Adenoma |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
16.99 | 16176798 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
16.99 | 6695378 |
MESH:D000236 |
Adenoma |
|
Dimethylnitrosamine |
16.99 | 19555203 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
16.99 | 6695378 10545420 |
MESH:D000236 |
Adenoma |
|
resveratrol |
16.99 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
7.88 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
7.88 | 16835633 |
MESH:D000309 |
Adrenal Insufficiency |
|
Dehydroepiandrosterone |
5.17 | 17302879 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Paraquat |
3.17 | 11874814 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
3.96 | 21441931 |
MESH:D000437 |
Alcoholism |
|
Mecamylamine |
5.16 | 20201817 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.12 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Copper |
4.08 | 16410023 16325427 17119284 16962711 16886094 16866297 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
4.08 | 16162502 16183991 |
MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
3.90 | 15469931 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
Copper |
3.89 | 10694572 |
MESH:D000707 |
Anaphylaxis |
|
mangiferin |
4.88 | 14669257 16536907 |
MESH:D000740 |
Anemia |
|
Phenacetin |
12.07 | 2444515 |
MESH:D000740 |
Anemia |
|
phenylhydrazine |
12.07 | 2444515 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
12.07 | 11748828 |
MESH:D000743 |
Anemia, Hemolytic |
|
Phenacetin |
14.18 | 17082564 17698508 1949026 |
MESH:D000743 |
Anemia, Hemolytic |
|
phenylhydrazine |
14.18 | 17698508 17084956 17082564 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
14.18 | 17084956 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Copper |
4.34 | 16614410 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.22 | 10982225 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.48 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
8.36 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
8.36 | 15238619 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
10.22 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tosylphenylalanyl Chloromethyl Ketone |
10.22 | 18706406 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
10.22 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.10 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.13 | 16456186 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
4.37 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
mangiferin |
8.97 | 18450471 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
8.97 | 11922910 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
8.97 | 16873680 17967414 |
MESH:D001284 |
Atrophy |
|
fulvestrant |
4.27 | 11514358 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.51 | 18445737 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
3.81 | 19761891 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.82 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
12.11 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
12.11 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
12.11 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.17 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.35 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.08 | 14601052 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
8.06 | 11985600 |
MESH:D001862 |
Bone Resorption |
|
mangiferin |
8.06 | 9881647 |
MESH:D001919 |
Bradycardia |
|
Isoproterenol |
4.58 | 6740701 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
3.68 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Copper |
7.43 | 17079463 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
7.43 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
15.90 | 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
15.90 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
15.90 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Copper |
15.90 | 15986119 17079463 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
15.90 | 18323546 17388661 15093573 11325840 12006526 18234424 15136595 16978400 17020986 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
15.90 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
15.90 | 17129689 15324884 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
15.90 | 16264153 16595493 16096432 15993339 18628466 15668708 18695136 16826403 19526202 18234424 15136595 15994142 17983394 15939500 17369602 15567936 16115903 15634643 11325840 16935488 15692762 18382427 17426702 16322301 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
15.90 | 17289903 19861407 14630087 17261762 17018787 16675129 12948864 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
fulvestrant |
15.90 | 18984771 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
15.90 | 16873071 17200150 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
indole-3-carbinol |
15.90 | 16082211 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
15.90 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
15.90 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
15.90 | 17534123 17651959 16393696 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
15.90 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
15.90 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
3.98 | 16813970 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
4.92 | 16962696 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.85 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.19 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Dimethylnitrosamine |
11.22 | 19555203 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
11.22 | 10545420 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
11.22 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.54 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
19.92 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
19.92 | 12907637 12619106 21507988 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
19.92 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
19.92 | 15948411 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
19.92 | 16023760 18059187 16234567 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
19.92 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
19.92 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
19.92 | 19519916 12508355 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
19.92 | 16227395 19321006 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
19.92 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.38 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
9.46 | 16152834 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
9.46 | 16675471 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
4.36 | 17234771 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
5.79 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
5.79 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
11.95 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Dimethylnitrosamine |
11.95 | 16033868 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
11.95 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
11.95 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
11.95 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
|
Copper |
13.37 | 17327471 |
MESH:D006332 |
Cardiomegaly |
|
Isoproterenol |
13.37 | 11179087 7544033 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
13.37 | 19794523 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
13.37 | 16120746 18850075 18670907 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.11 | 15811867 17351982 17382496 17519947 15792986 17007740 16731534 16242529 16651473 16269455 16455267 17131338 17924179 15505089 17974986 16364871 16612575 16109756 16952015 15476868 16278810 17308081 17928571 18627295 17329180 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.70 | 17334414 16243910 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
6.05 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
6.05 | 15458977 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
5.93 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
5.93 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
12.44 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
12.44 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
12.44 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
12.44 | 16192471 |
OMIM:610127 |
CEROID LIPOFUSCINOSIS, NEURONAL, 10 |
marker/mechanism |
|
| |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
3.98 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.64 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
6.21 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
6.21 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.54 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
4.78 | 12621046 8697196 15340226 15668235 16354765 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
4.78 | 9407595 |
MESH:D019970 |
Cocaine-Related Disorders |
|
Cocaine |
5.11 | 19606084 |
MESH:D003092 |
Colitis |
|
resveratrol |
7.66 | 16474422 |
MESH:D003092 |
Colitis |
|
Tretinoin |
7.66 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
5.02 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
5.02 | 17191121 19440933 15741050 11134977 16640504 17148506 19056647 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
5.02 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
3.13 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
3.13 | 18852136 18095365 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
3.13 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.54 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.34 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
sodium arsenate |
3.36 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.36 | 15322242 20055451 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.36 | 16925845 14991402 10589399 9211117 17551590 9664655 8800419 9142499 9125849 9224671 |
MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
3.98 | 16002989 12952375 |
MESH:D003457 |
Cryptosporidiosis |
|
mangiferin |
5.24 | 16547730 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
4.37 | 12913760 12161096 12388444 16651033 15643279 18710439 18483878 17010015 10700343 11948286 18372110 16614059 18433785 10498854 16413132 15276878 18295254 16989017 18093676 17979934 |
MESH:D003704 |
Dementia |
|
Methylmercury Compounds |
4.45 | 16140633 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.11 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
15.78 | 10990075 15331540 11751995 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
mangiferin |
15.78 | 12093613 19028559 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
15.78 | 19496084 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
15.78 | 16873680 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
5.32 | 18772604 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Dehydroepiandrosterone |
5.32 | 16616286 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
6.14 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
mangiferin |
6.14 | 11315760 9881663 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.14 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
12.21 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
mangiferin |
12.21 | 19960420 19706694 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
12.21 | 16286809 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
12.30 | 19370779 17906064 11834606 11529661 12958197 14550746 16081117 19739265 14986274 11287661 12705907 12540782 17522070 10915739 14725611 12153990 18071297 19164858 11421492 19420014 11461765 11739529 16781746 12392966 19085960 11743745 19416960 12594235 10774834 16393943 16109766 15619225 16227642 18713872 15968718 2444490 16177239 19923254 17562736 16485898 10663392 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Dimethylnitrosamine |
12.30 | 8172417 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
12.30 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
fumonisin B1 |
12.30 | 16221962 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
sodium arsenate |
12.30 | 18186108 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
12.30 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.48 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
6.56 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
6.56 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.00 | 18367378 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
12.04 | 17259670 12083418 |
MESH:D004487 |
Edema |
|
pirinixic acid |
12.04 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
12.04 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
12.04 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
9.88 | 16714409 18230668 15322242 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
9.88 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
3.45 | 17872969 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
9.87 | 16402032 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
9.87 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
18.90 | 15700306 16804899 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
18.90 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
18.90 | 18566989 11473722 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
18.90 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
18.90 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.49 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.53 | 18037988 |
MESH:D019446 |
Endotoxemia |
|
endotoxin, Escherichia coli |
9.03 | 18509659 17637181 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
9.03 | 17637181 15328337 15821434 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.25 | 17923197 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
3.63 | 11006010 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
8.75 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
8.75 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Dimethylnitrosamine |
8.75 | 17016578 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
8.75 | 16704527 15264214 15150132 15547733 15547721 15878914 16805852 16510608 15623463 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
7.28 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
7.28 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
14.36 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
14.36 | 19004024 17967931 18296743 19551842 |
MESH:D005234 |
Fatty Liver |
|
mangiferin |
14.36 | 15975614 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
14.36 | 20131406 19236843 |
MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
3.26 | 16534752 16611131 16002989 16513791 15751030 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.86 | 11858732 |
MESH:D005334 |
Fever |
|
endotoxin, Escherichia coli |
7.99 | 16997862 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
7.99 | 9205823 11852909 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
3.98 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
4.33 | 14633661 10962813 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
26.86 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
26.86 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Emodin |
26.86 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
26.86 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
26.86 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
26.86 | 17994277 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.06 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
4.34 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.61 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
13.52 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
13.52 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
13.52 | 19804834 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
13.52 | 17312396 |
MESH:D005910 |
Glioma |
|
Quercetin |
2.78 | 17643826 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
4.90 | 11389073 |
MESH:D005911 |
Gliosis |
|
Paraquat |
4.54 | 11124998 |
MESH:D018149 |
Glucose Intolerance |
|
sodium arsenate |
4.51 | 19446573 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
3.97 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
4.44 | 16376943 15172196 11014644 |
MESH:D006261 |
Headache |
|
Nitroglycerin |
4.57 | 11554966 11284996 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
6.41 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
6.41 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.54 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
9.02 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
9.02 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
9.02 | 14991402 9664655 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
6.69 | 16330681 14766674 18674790 17888722 16707910 12587719 17875725 16495754 16244372 16144979 16879835 16244371 18006777 |
MESH:D006331 |
Heart Diseases |
|
mangiferin |
6.69 | 12093613 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
9.63 | 17481944 |
MESH:D006333 |
Heart Failure |
|
Isoproterenol |
9.63 | 18097624 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
9.63 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.36 | 15692506 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.81 | 15720958 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
3.85 | 16366002 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
4.69 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.79 | 11000095 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
4.91 | 14986274 |
MESH:D006521 |
Hepatitis, Chronic |
|
Copper |
4.66 | 17338147 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Copper |
4.57 | 17276780 16607473 17109627 19888908 17182432 |
MESH:D006529 |
Hepatomegaly |
|
fumonisin B1 |
15.89 | 16221962 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
15.89 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
15.89 | 16221962 18467677 19772884 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
15.89 | 16120746 12621046 15340226 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.41 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
mangiferin |
8.25 | 10715843 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
8.25 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
6.02 | 17606976 16135485 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
6.02 | 15147373 18501091 17606976 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.14 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.42 | 16959395 16354765 8697196 15340226 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
10.26 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
10.26 | 12083418 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
10.26 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
7.40 | 21332399 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
7.40 | 17188708 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
3.97 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
7.47 | 20558911 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
7.47 | 11834736 18262572 |
MESH:D006946 |
Hyperinsulinism |
|
mangiferin |
4.49 | 11315760 9881663 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
12.36 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
mangiferin |
12.36 | 15975614 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
12.36 | 16873680 |
MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
3.84 | 14722030 12960047 |
MESH:D006967 |
Hypersensitivity |
|
mangiferin |
4.17 | 16536907 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
6.98 | 10903974 |
MESH:D006973 |
Hypertension |
|
Quercetin |
6.98 | 18356687 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
6.98 | 18850075 18670907 |
MESH:D006984 |
Hypertrophy |
|
Isoproterenol |
4.64 | 12791704 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.77 | 17488730 |
MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
3.99 | 16002989 |
MESH:D007022 |
Hypotension |
|
Isoproterenol |
4.24 | 6740701 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
11.38 | 16076520 |
MESH:D007154 |
Immune System Diseases |
|
mangiferin |
11.38 | 16076520 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.05 | 17600658 |
MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
3.78 | 15036965 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
12.74 | 7193160 16517039 |
MESH:D007248 |
Infertility, Male |
|
fulvestrant |
12.74 | 11514358 |
MESH:D007248 |
Infertility, Male |
|
Paraquat |
12.74 | 4850670 |
MESH:D007248 |
Infertility, Male |
|
pirimiphos methyl |
12.74 | 17604518 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
18.84 | 20412841 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
18.84 | 17296493 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
18.84 | 17237260 17963957 9205823 17255318 12878042 |
MESH:D007249 |
Inflammation |
|
mangiferin |
18.84 | 15222974 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
18.84 | 12083418 |
MESH:D007249 |
Inflammation |
|
resveratrol |
18.84 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
18.84 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
9.13 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
9.13 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
18.75 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
18.75 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
18.75 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
mangiferin |
18.75 | 11315760 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
18.75 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.18 | 17994277 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.07 | 17255318 |
MESH:D007511 |
Ischemia |
|
mangiferin |
4.68 | 16806951 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.11 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
8.11 | 15992940 17551590 |
MESH:D007627 |
Keloid |
|
Quercetin |
4.36 | 17086741 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.82 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
18.93 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
18.93 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
18.93 | 15699352 16775033 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
18.93 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
mangiferin |
18.93 | 12093613 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
18.93 | 16962696 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Copper |
8.54 | 16518626 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
8.54 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
9.54 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
9.54 | 15003126 14681315 16762066 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
9.54 | 15610895 |
MESH:D007859 |
Learning Disorders |
|
Copper |
12.92 | 17134702 |
MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
12.92 | 17184923 |
MESH:D007859 |
Learning Disorders |
|
mangiferin |
12.92 | 19182383 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
12.20 | 10602166 |
MESH:D007938 |
Leukemia |
|
Genistein |
12.20 | 18980019 17468513 |
MESH:D007938 |
Leukemia |
|
Quercetin |
12.20 | 17468513 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
12.20 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.53 | 16085563 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.20 | 17658394 17802794 18587576 18172266 17008537 17296974 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Emodin |
4.48 | 17077332 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
7.51 | 10373061 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
mangiferin |
7.51 | 15498116 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.15 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
1.96 | 16294345 19850784 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
6.36 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
6.36 | 16140955 12679006 17294898 16788101 17107899 19075265 17649720 17506722 19642359 16935935 9834237 15748426 17712046 16331271 16823087 17301526 17361223 19029980 17217047 16766008 19035177 19225113 16891316 17368321 17339181 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
9.75 | 10052129 11830472 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
9.75 | 15821434 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
4.62 | 8812269 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
2.86 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.52 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dimethylnitrosamine |
15.83 | 16627068 18371158 16009107 15366600 15591649 18237412 16169303 18364076 15161499 18672772 17198567 15081153 18637143 16270385 16544323 15339415 15793283 17348192 17203207 17640959 18567088 14709902 15723089 15492853 17724770 17666798 16603200 14659978 17881167 15086199 17534399 15942678 18629640 17432682 15138612 15763062 18210741 17036385 12925901 15864749 15744066 16042886 15577212 15733078 15798949 12918455 18239293 18095165 15298665 15842777 17196135 15067225 15504291 14568256 16570917 14643895 17465448 15369754 17719030 15479170 15099470 17201889 14726149 15571005 15383259 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
15.83 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Emodin |
15.83 | 15288473 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
15.83 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
15.83 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
15.83 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
15.83 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
15.83 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
15.83 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
15.83 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.47 | 19460945 11587558 19014921 16611625 12969438 12587719 19784758 16610002 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
7.90 | 17185352 16871587 |
MESH:D017114 |
Liver Failure, Acute |
|
Dimethylnitrosamine |
7.90 | 17457977 |
MESH:D008113 |
Liver Neoplasms |
|
2-nitrofluorene |
48.35 | 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
48.35 | 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
48.35 | 2125692 15890375 18177683 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
48.35 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Copper |
48.35 | 20302851 |
MESH:D008113 |
Liver Neoplasms |
|
Dehydroepiandrosterone |
48.35 | 18709148 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
48.35 | 16712894 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Dimethylnitrosamine |
48.35 | 15890375 3113478 |
MESH:D008113 |
Liver Neoplasms |
|
Methapyrilene |
48.35 | 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
48.35 | 18709148 14757943 |
MESH:D008113 |
Liver Neoplasms |
|
Piperonyl Butoxide |
48.35 | 18648771 19690152 15890375 20101389 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
48.35 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
48.35 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
48.35 | 19321006 19073162 20405173 19812893 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
48.35 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
22.07 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Dehydroepiandrosterone |
22.07 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Dimethylnitrosamine |
22.07 | 1848544 15603536 6150874 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
22.07 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
22.07 | 1399818 598648 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
22.07 | 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
22.07 | 12151625 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
3.42 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
13.25 | 18508827 19931552 15172992 9255578 15893417 18813816 12438228 14755239 16401635 16061637 17139156 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
13.25 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
13.25 | 18816296 20869020 18569708 18520028 20464547 6695378 20135361 20064080 17053015 |
MESH:D008175 |
Lung Neoplasms |
|
Dimethylnitrosamine |
13.25 | 16061637 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
13.25 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
mangiferin |
13.25 | 18520028 18569708 18816296 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
13.25 | 10545420 1399818 20512841 9230183 21163286 20970405 6695378 16271038 17909032 7750092 11893704 15390079 16337739 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
13.25 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
13.25 | 19555203 11884234 |
MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
4.54 | 15166399 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
10.08 | 12854902 |
MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
10.08 | 15700306 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
10.08 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
8.60 | 16675587 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
8.60 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
11.73 | 11911406 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
11.73 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
11.73 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
3.97 | 15621674 |
MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
4.89 | 16002989 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
3.64 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Dehydroepiandrosterone |
14.46 | 16457693 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
14.46 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
14.46 | 11807958 17203775 11408345 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
14.46 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
14.46 | 11606380 8985016 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
3.86 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.51 | 17453147 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
4.36 | 16827129 |
MESH:D008545 |
Melanoma |
|
resveratrol |
4.36 | 17992120 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
4.36 | 16752155 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
8.86 | 19513568 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
8.86 | 16388313 |
MESH:D008569 |
Memory Disorders |
|
mangiferin |
8.39 | 19182383 |
MESH:D008569 |
Memory Disorders |
|
Methylmercury Compounds |
8.39 | 18436314 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
3.83 | 16940565 |
MESH:D007706 |
Menkes Kinky Hair Syndrome |
|
Copper |
5.27 | 17109627 17268249 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
2.78 | 17638057 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.83 | 17112576 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.17 | 16801185 |
MESH:D008708 |
Methemoglobinemia |
|
Nitroglycerin |
8.05 | 3537620 |
MESH:D008708 |
Methemoglobinemia |
|
Phenacetin |
8.05 | 16296465 1949026 4834387 3537620 |
MESH:D020326 |
Migraine without Aura |
|
Nitroglycerin |
4.55 | 14659530 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
3.95 | 15792986 |
MESH:D009041 |
Motion Sickness |
|
Dextroamphetamine |
4.90 | 1613127 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.71 | 16381670 |
MESH:D009069 |
Movement Disorders |
|
Methylmercury Compounds |
4.76 | 18436314 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.18 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
3.03 | 16267019 17935668 16490592 17164350 17049120 14749477 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.26 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
2.91 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
sodium arsenate |
4.31 | 18186108 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
2.70 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Cocaine |
31.13 | 18072171 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
31.13 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
31.13 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
Isoproterenol |
31.13 | 15740881 17052832 19172585 16538859 16697266 16584858 19595682 |
MESH:D009203 |
Myocardial Infarction |
|
mangiferin |
31.13 | 16584858 16538859 16697266 17052832 19172585 |
MESH:D009203 |
Myocardial Infarction |
|
Nitroglycerin |
31.13 | 14729435 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
31.13 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
31.13 | 19595682 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
31.13 | 16317513 17188708 17125593 16456233 17015251 16525036 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
7.38 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
7.38 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
16.38 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
16.38 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
16.38 | 16411023 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
16.38 | 19207477 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.15 | 17322642 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
2.68 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
15.40 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
15.40 | 18854779 |
MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
15.40 | 15313581 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
15.40 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
15.40 | 15185748 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
15.40 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
3.41 | 8985016 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Copper |
8.33 | 17308104 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
8.33 | 17289903 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.17 | 16899518 16636307 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.82 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
7.57 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
7.57 | 15640375 16889571 |
MESH:D009410 |
Nerve Degeneration |
|
mangiferin |
7.32 | 17433543 |
MESH:D009410 |
Nerve Degeneration |
|
Paraquat |
7.32 | 16893418 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
30.80 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
30.80 | 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
30.80 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
30.80 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
30.80 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
30.80 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenate |
6.21 | 19446573 10525206 18186108 11749123 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
6.21 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
6.05 | 8761367 15176712 16115947 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
6.05 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
6.68 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
6.68 | 17652729 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
4.28 | 12837982 8761367 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
8.82 | 17929310 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
8.82 | 17929310 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
3.77 | 8291058 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
4.36 | 9802331 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
3.79 | 20518802 21332399 11836018 17217161 19632207 18674790 16723640 20132043 18457598 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
3.79 | 20558911 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.11 | 16517039 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
2.86 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Dehydroepiandrosterone |
19.46 | 16397352 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
19.46 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
19.46 | 19495926 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
19.46 | 17513867 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.62 | 15930896 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.38 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
9.35 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
9.35 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
9.35 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
9.35 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
8.43 | 16870215 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
8.43 | 18093676 12161096 |
MESH:D010146 |
Pain |
|
Tretinoin |
8.43 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
10.25 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
10.25 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
10.25 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
10.25 | 15976015 |
MESH:D010300 |
Parkinson Disease |
|
mangiferin |
4.96 | 17433543 |
MESH:D010300 |
Parkinson Disease |
|
Paraquat |
4.96 | 11181820 11445065 16140633 12911755 11124998 15451049 16510128 15824117 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Paraquat |
3.84 | 16190885 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.63 | 12520081 |
MESH:D010518 |
Periodontitis |
|
mangiferin |
4.98 | 19026997 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.53 | 17983394 |
MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
4.55 | 14722030 |
MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
4.08 | 16977796 15687265 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.53 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
9.10 | 12224865 11605937 |
MESH:D011014 |
Pneumonia |
|
Paraquat |
9.10 | 12504350 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
2.98 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
7.38 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
7.38 | 19056647 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.43 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
30.05 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
30.05 | 17184923 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Methylmercury Compounds |
30.05 | 18436314 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
30.05 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
30.05 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
30.05 | 11896295 11399792 11118676 11222880 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
8.73 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
8.73 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 17013881 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.15 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.15 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Copper |
3.15 | 17308104 17079463 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
3.15 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
3.15 | 17136230 15846301 15046698 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.15 | 16868541 16729912 15749863 15897917 16888761 18437689 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.15 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
3.15 | 15256057 15378649 16925846 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
3.15 | 17292933 14715546 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
3.15 | 16731767 17675339 17804756 17636462 17718901 15767336 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.05 | 16636307 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
1.98 | 16882103 |
MESH:D011618 |
Psychotic Disorders |
|
Cocaine |
4.37 | 16134406 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.18 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.18 | 10548101 |
MESH:D011654 |
Pulmonary Edema |
|
Isoproterenol |
4.63 | 10903255 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
5.08 | 16636934 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Paraquat |
5.08 | 16324872 17997886 |
MESH:D011833 |
Radiation Injuries, Experimental |
|
mangiferin |
5.78 | 15830843 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
3.63 | 17922066 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
4.96 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
5.45 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
5.45 | 17058453 17520802 16317513 16314181 15827377 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Paraquat |
3.35 | 11700416 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.31 | 10835634 |
MESH:D012135 |
Respiratory Sounds |
|
Paraquat |
3.47 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.26 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Paraquat |
3.40 | 16458197 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.54 | 16116481 16283617 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.46 | 16767912 17710206 18313854 17203757 15625365 15675481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
3.66 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.18 | 17846226 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
4.92 | 16862918 |
MESH:D012559 |
Schizophrenia |
|
Copper |
2.99 | 16842975 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.26 | 16636934 |
MESH:D012640 |
Seizures |
|
Cocaine |
5.82 | 10454489 |
MESH:D012640 |
Seizures |
|
Mecamylamine |
5.82 | 12660363 |
MESH:D012772 |
Shock, Septic |
|
endotoxin, Escherichia coli |
9.49 | 18063050 |
MESH:D012772 |
Shock, Septic |
|
mangiferin |
9.49 | 15177305 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
14.46 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
14.46 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
14.46 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
14.46 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
14.46 | 16467112 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
3.97 | 17203757 15625365 16767912 |
MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
4.09 | 16002989 16709447 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
4.90 | 16517039 |
MESH:D013158 |
Splenic Diseases |
|
Dimethylnitrosamine |
4.65 | 12587719 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
4.07 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Dimethylnitrosamine |
4.07 | 16033868 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
4.07 | 17575124 12958204 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
4.07 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
mangiferin |
3.75 | 17918041 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
3.94 | 16321402 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.38 | 16684133 16045194 |
MESH:D013436 |
Sulfhemoglobinemia |
|
Phenacetin |
5.93 | 978859 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
4.45 | 12837982 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.63 | 15821434 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.28 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
5.75 | 16010429 17909728 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
5.75 | 17045167 16026305 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.06 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
8.14 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
8.14 | 16051514 |
MESH:D014235 |
Trichinellosis |
|
mangiferin |
5.44 | 14669257 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.82 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
16.23 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
16.23 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
16.23 | 16712894 16452187 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
16.23 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Phenacetin |
16.23 | 11144890 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
16.23 | 16720314 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.42 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
18.34 | 16175088 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
indole-3-carbinol |
18.34 | 16082211 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
18.34 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
18.34 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
11.75 | 14652134 |
MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
11.75 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
7.86 | 16690809 15809267 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
7.86 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
3.99 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.36 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
3.84 | 16513791 16002989 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
3.97 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
13.87 | 17334414 17638931 17678736 16364871 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Isoproterenol |
13.87 | 18097624 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
13.87 | 17488730 |
MESH:D020257 |
Ventricular Remodeling |
|
Isoproterenol |
5.08 | 18097624 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.48 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.63 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.22 | 16723640 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.45 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.82 | 17120751 |